CRS Research Says Cannabis Rescheduling Future ‘Unclear’ as Legal Challenges Emerge
- January 29, 2025
Ben Stevens, Business of Cannabis
Last week, Trump signed dozens of executive orders impacting everything from climate change policy, health and medical research, immigration, to diversity programming.
Despite this, the cannabis industry has been left largely in the dark as to the future of former President Biden’s cannabis rescheduling project.
Marijuana Moment reported than new analysis from the CRS, focusing on a number of cannabis-specific issues for the new administration to consider, determined that it ‘remains to be seen’ how Trump will handle rescheduling.
Furthermore, it is ‘unknown’ whether the Drug Enforcement Administration (DEA) would finalize the proposed rule change.
Elsewhere, a government transparency group, Protect the Public’s Trust (PPT), is suing the US Department of Health and Human Services (HHS) for failing to release records related to the Biden administration’s cannabis rescheduling process.
PPT alleges that HHS has ignored Freedom of Information Act (FOIA) requests for over 418 days, withholding communications between HHS, DOJ, DEA, and FDA about moving cannabis from Schedule I to Schedule III. The lawsuit seeks to compel HHS to release the documents.